Homology: Homology Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

Homology Medicines, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 112.96 million compared to USD 5.01 million a... Homology Medicines, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 112.96 million compared to USD 5.01 million a year ago. Basic loss per share from continuing operations was USD 1.95 compared to USD 0.09 a year ago. Diluted loss per share from continuing operations was USD 1.95 compared to USD 0.09 a year ago.